STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Submission of Matters to a Vote of Security Holders
The annual meeting of the shareholders of the Company (the “Annual Meeting”) was held on June 20, 2019. 44,472,846 shares of common stock were outstanding on the record date for the Annual Meeting (April 23, 2019) and entitled to vote at the Annual Meeting. The voting was as follows:
About STAAR Surgical Company (NASDAQ:STAA)
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.
